iBio Inc (NYSEAMERICAN:IBIO) Stock Falls As Investors Are Unhappy With Quarterly Earnings

February 15, 2022

Those who are looking into premarket action this morning may have noticed that the stock of the biopharmaceutical development company iBio Inc (NYSEAMERICAN:IBIO) suffered from a significant selloff. The stock has gone down by as much as 7% in the premarket trading period so far and it is going to be interesting to see if it can make a recovery during the trading day. Trading Data On Monday, IBIO stock…

Read More >>